⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9977 | 1.00 | — | — | |
| Pyrazine SCHEMBL2538511 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL8799455 | 0.96 | — | — | |
| SCHEMBL31164666 | 0.96 | — | — | |
| SCHEMBL28122131 | 0.96 | — | — | |
| SCHEMBL1685846 | 0.93 | — | — | |
| Formaldehyde SCHEMBL27467279 | 0.89 | — | — | |
| Pyridazine SCHEMBL28033129 | 0.89 | TSHR (0.33) | — | |
| SCHEMBL28591258 | 0.89 | — | — | |
| SCHEMBL1905671 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746920-A1 | HEMATOPOIETIC CELL TARGETING CONJUGATES AND RELATED METHODS | Marrow Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4151597-B1 | INORGANIC POROUS SUBSTRATE, INORGANIC POROUS SUPPORT, AND NUCLEIC ACID PRODUCTION METHOD | SUMITOMO CHEMICAL CO (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-12570974-B2 | Oligonucleotides for controlling tau splicing, and uses thereof | KNC LABORATORIES CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| WO-2025217275-A2 | IMMUNE CELL TARGETED COMPOSITIONS AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2025-10-16 | — | — | WO | disclosed |
| WO-2025137480-A1 | AUTOMATED DESIGN OF PROTEIN-BINDING RIBOSWITCHES FOR SENSING HUMAN BIOMARKERS IN A CELL-FREE EXPRESSION SYSTEM | THE PENN STATE RESEARCH FOUNDATION (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-115873020-B | RAS inhibitors | 锐新医药公司 | 2025-06-13 | — | — | CN | disclosed |
| WO-2025101881-A1 | HETEROATOM CONTAINING PEPTIDOMIMETICS TARGETING VIRAL PROTEASES | EMORY UNIVERSITY (US) | 2025-05-15 | — | — | WO | disclosed |
| WO-2025097022-A1 | MULTICOMPONENT SYSTEMS FOR SITE-SPECIFIC GENOME MODIFICATIONS | ADDITION THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119947691-A | Composition comprising a photochemical ultraviolet absorber precursor and a compound for increasing the rate of photochemical conversion thereof | 罗卡福拉达有限公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2025072331-A1 | CAS NUCLEASES AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC (US) | 2025-04-03 | — | — | WO | disclosed |
| EP-4151597-A1 | INORGANIC POROUS SUBSTRATE, INORGANIC POROUS SUPPORT, AND NUCLEIC ACID PRODUCTION METHOD | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-03-22 | — | — | EP | disclosed |
| EP-3529373-B1 | METHOD FOR DETERMINING THE PRESENCE, ABSENCE OR AMOUNT OF TWO OR MORE TARGET POLYNUCLEOTIDES | OXFORD NANOPORE TECH PLC (GB) | 2022-12-07 | — | — | EP | disclosed |
| WO-2022251663-A2 | NOVEL UNIVERSAL ANTI-RNA VIRUS AGENTS | EMORY UNIVERSITY (US) | 2022-12-01 | — | — | WO | disclosed |
| WO-2022217155-A2 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | EMORY UNIVERSITY (US) | 2022-10-13 | — | — | WO | disclosed |
| WO-2022217154-A2 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | EMORY UNIVERSITY (US) | 2022-10-13 | — | — | WO | disclosed |
| WO-2022217153-A2 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | EMORY UNIVERSITY (US) | 2022-10-13 | — | — | WO | disclosed |
| US-11390910-B2 | Method | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2022-07-19 | — | — | US | disclosed |
| WO-2022098371-A1 | PRODRUGS OF 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGUES FOR ANTIVIRAL TREATMENT | YAN MATTHEW (US) | 2022-05-12 | — | — | WO | disclosed |
| CN-112239452-B | Electron transport type heteroanthracene derivative and organic electroluminescent device thereof | 武汉尚赛光电科技有限公司 | 2022-05-10 | — | — | CN | disclosed |
| EP-3980400-A1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | Emory University (US) | 2022-04-13 | — | — | EP | disclosed |